Addressing poorly-understood tumour-host interactions to enhance immune system-centred treatment and care interventions in childhood, adolescent, adult and elderly cancer patients.
This Horizon Europe research and innovation action focuses on advancing the understanding and treatment of poorly-understood cancers across all age groups. It aims to leverage innovative research and digital technologies to improve immune system-centred interventions and overall cancer care. The program fosters a collaborative approach, encouraging synergies with existing EU initiatives to achieve a significant societal impact.
Who is Funded: Cancer Research & Care Beneficiaries
The program primarily targets research and health professionals, innovators, and related organizations across all EU Member States and Associated Countries, aiming to improve cancer understanding, prevention, diagnostics, treatment, and patient quality of life.
What is Funded: Research & Innovation in Oncology
This program funds research and innovation projects focused on poorly-understood cancers, emphasizing immune system-centred therapies and leveraging advanced digital technologies. The scope covers fundamental research through to implementation in health systems, allowing for comprehensive advancements in cancer care.
Type and Scope of Funding for Cancer Initiatives
The funding is provided as grants, with significant amounts allocated per project to support in-depth research and innovation. The program is designed to facilitate substantial contributions towards its cancer mission objectives.
Conditions & Requirements for Cancer Mission Proposals
Applicants must adhere to general Horizon Europe conditions, including specific thresholds for evaluation. Collaboration in consortia is required, with an emphasis on integrating socio-economic and humanities expertise.
Application Procedure: Streamlined Submission & Evaluation
The application process involved a single-stage submission. Proposals were rigorously evaluated against specific criteria, with an emphasis on scientific excellence and societal impact. Evaluation results were communicated to applicants in August 2023.
Legal Basis of the Cancer Mission Program
The program operates under the comprehensive legal framework of Horizon Europe, ensuring compliance with EU regulations and strategic objectives for research and innovation.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
12,000,000 €
Allocated Budget:
Total for topic: 36,682,904.01 €. Individual projects: 7,000,000 € to 12,000,000 €.
Open Until:
31.12.2027
Award Channel:
Framework Programme Call
Region:
EU Member States and Associated Countries.
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology, Other
Beneficiaries:
Cancer patients (childhood, adolescent, adult, and elderly), cancer survivors and their families, and society in general.
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Product Development, Implementation, Service Delivery, Policy Development, Capacity Building, Awareness Campaigns
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Additional Partners:
HealthyCloud, EOSC-Life, Photonics21 partnership (including Photon Hub Europe support service), Innovative Health Initiative partnership, European Health Data Space (EHDS) Joint Action, 1+ Million Genomes (1+MG), Beyond One Million Genomes (B1MG), EBrains research infrastructure, EIT Health Knowledge Innovation Community initiatives, EOSC4cancer, canSERV, other EU programmes, and the Knowledge Centre on Cancer (KCC).
Website: